Prognostic Value of Procalcitonin for Morbidity and Mortality in Patients after Cardiac Surgery

Table 1

The demographic and medical characteristics of the 100 patients participated in the study.

Characteristic		All patients (n = 100)
Age, mean ± SD		63.0 ± 10.53
Gender	Male	67 (67)
	Female	33 (33)
Smoker	Yes	13 (13)
	No	87 (87)
No. of grafts, mean ± SD		3.9 ± 0.65
Type of dysrhythmia	No	86 (86)
	VT	6 (6)
	AF	8 (8)
Ejection fraction, %	20–29	12 (12)
	30–39	16 (16)
	40–49	26 (26)
	≥50	46 (46)
DM	Yes	36 (36)
	No	64 (64)
DLP	Yes	46 (46)
	No	54 (54)
HTN	Yes	57 (57)
	No	43 (43)
CVA	Yes	4 (4.0)
	No	96 (96.0)

VT, ventricular tachycardia; AF, atrial fibrillation; DM, diabetes mellitus; DLP, dislipidemia; HTN, hypertension; CVA, cerebrovascular accident.